目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary €“ Chart on Market Overview
Exhibit 02: Executive Summary €“ Data Table on Market Overview
Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics
Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Type
Exhibit 06: Executive Summary €“ Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary €“ Chart on Incremental Growth
Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global neuromuscular disease therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size €“ Data Table on global neuromuscular disease therapeutics market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size €“ Type Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size €“ End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Biologics - Market size and forecast 2022-2027
Exhibit 34: Chart on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Biologics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
6.4 Small molecules - Market size and forecast 2022-2027
Exhibit 38: Chart on Small molecules - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Small molecules - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Small molecules - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Small molecules - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user
7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2022-2027
Exhibit 48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.4 Clinics - Market size and forecast 2022-2027
Exhibit 52: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 56: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ million)
Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AFM-Telethon
Exhibit 111: AFM-Telethon - Overview
Exhibit 112: AFM-Telethon - Product / Service
Exhibit 113: AFM-Telethon - Key offerings
12.4 Aquestive Therapeutics Inc.
Exhibit 114: Aquestive Therapeutics Inc. - Overview
Exhibit 115: Aquestive Therapeutics Inc. - Business segments
Exhibit 116: Aquestive Therapeutics Inc. - Key offerings
Exhibit 117: Aquestive Therapeutics Inc. - Segment focus
12.5 Biogen Inc.
Exhibit 118: Biogen Inc. - Overview
Exhibit 119: Biogen Inc. - Product / Service
Exhibit 120: Biogen Inc. - Key offerings
12.6 Brainstorm Cell Therapeutics Inc.
Exhibit 121: Brainstorm Cell Therapeutics Inc. - Overview
Exhibit 122: Brainstorm Cell Therapeutics Inc. - Product / Service
Exhibit 123: Brainstorm Cell Therapeutics Inc. - Key offerings
12.7 F. Hoffmann La Roche Ltd.
Exhibit 124: F. Hoffmann La Roche Ltd. - Overview
Exhibit 125: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 126: F. Hoffmann La Roche Ltd. - Key news
Exhibit 127: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 128: F. Hoffmann La Roche Ltd. - Segment focus
12.8 Ionis Pharmaceuticals Inc.
Exhibit 129: Ionis Pharmaceuticals Inc. - Overview
Exhibit 130: Ionis Pharmaceuticals Inc. - Business segments
Exhibit 131: Ionis Pharmaceuticals Inc. - Key news
Exhibit 132: Ionis Pharmaceuticals Inc. - Key offerings
Exhibit 133: Ionis Pharmaceuticals Inc. - Segment focus
12.9 Mitsubishi Chemical Corp.
Exhibit 134: Mitsubishi Chemical Corp. - Overview
Exhibit 135: Mitsubishi Chemical Corp. - Business segments
Exhibit 136: Mitsubishi Chemical Corp. - Key offerings
Exhibit 137: Mitsubishi Chemical Corp. - Segment focus
12.10 Nippon Shinyaku Co. Ltd.
Exhibit 138: Nippon Shinyaku Co. Ltd. - Overview
Exhibit 139: Nippon Shinyaku Co. Ltd. - Business segments
Exhibit 140: Nippon Shinyaku Co. Ltd. - Key offerings
Exhibit 141: Nippon Shinyaku Co. Ltd. - Segment focus
12.11 Novartis AG
Exhibit 142: Novartis AG - Overview
Exhibit 143: Novartis AG - Business segments
Exhibit 144: Novartis AG - Key offerings
Exhibit 145: Novartis AG - Segment focus
12.12 Pfizer Inc.
Exhibit 146: Pfizer Inc. - Overview
Exhibit 147: Pfizer Inc. - Product / Service
Exhibit 148: Pfizer Inc. - Key news
Exhibit 149: Pfizer Inc. - Key offerings
12.13 PTC Therapeutics Inc.
Exhibit 150: PTC Therapeutics Inc. - Overview
Exhibit 151: PTC Therapeutics Inc. - Product / Service
Exhibit 152: PTC Therapeutics Inc. - Key offerings
12.14 Sanofi
Exhibit 153: Sanofi - Overview
Exhibit 154: Sanofi - Business segments
Exhibit 155: Sanofi - Key news
Exhibit 156: Sanofi - Key offerings
Exhibit 157: Sanofi - Segment focus
12.15 Sarepta Therapeutics Inc
Exhibit 158: Sarepta Therapeutics Inc - Overview
Exhibit 159: Sarepta Therapeutics Inc - Product / Service
Exhibit 160: Sarepta Therapeutics Inc - Key offerings
12.16 SGPharma Pvt. Ltd.
Exhibit 161: SGPharma Pvt. Ltd. - Overview
Exhibit 162: SGPharma Pvt. Ltd. - Product / Service
Exhibit 163: SGPharma Pvt. Ltd. - Key offerings
12.17 Viatris Inc.
Exhibit 164: Viatris Inc. - Overview
Exhibit 165: Viatris Inc. - Business segments
Exhibit 166: Viatris Inc. - Key news
Exhibit 167: Viatris Inc. - Key offerings
Exhibit 168: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
13.5 List of abbreviations
Exhibit 175: List of abbreviations

Exhibits:
Exhibits1: Executive Summary €“ Chart on Market Overview
Exhibits2: Executive Summary €“ Data Table on Market Overview
Exhibits3: Executive Summary €“ Chart on Global Market Characteristics
Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits5: Executive Summary €“ Chart on Market Segmentation by Type
Exhibits6: Executive Summary €“ Chart on Market Segmentation by End-user
Exhibits7: Executive Summary €“ Chart on Incremental Growth
Exhibits8: Executive Summary €“ Data Table on Incremental Growth
Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size €“ Data Table on global neuromuscular disease therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size €“ Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size €“ End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Biologics - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Small molecules - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Small molecules - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Small molecules - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Small molecules - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on End-user - Market share 2022-2027 (%)
Exhibits45: Data Table on End-user - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by End-user
Exhibits47: Data Table on Comparison by End-user
Exhibits48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by End-user ($ million)
Exhibits61: Data Table on Market opportunity by End-user ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AFM-Telethon - Overview
Exhibits112: AFM-Telethon - Product / Service
Exhibits113: AFM-Telethon - Key offerings
Exhibits114: Aquestive Therapeutics Inc. - Overview
Exhibits115: Aquestive Therapeutics Inc. - Business segments
Exhibits116: Aquestive Therapeutics Inc. - Key offerings
Exhibits117: Aquestive Therapeutics Inc. - Segment focus
Exhibits118: Biogen Inc. - Overview
Exhibits119: Biogen Inc. - Product / Service
Exhibits120: Biogen Inc. - Key offerings
Exhibits121: Brainstorm Cell Therapeutics Inc. - Overview
Exhibits122: Brainstorm Cell Therapeutics Inc. - Product / Service
Exhibits123: Brainstorm Cell Therapeutics Inc. - Key offerings
Exhibits124: F. Hoffmann La Roche Ltd. - Overview
Exhibits125: F. Hoffmann La Roche Ltd. - Business segments
Exhibits126: F. Hoffmann La Roche Ltd. - Key news
Exhibits127: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits128: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits129: Ionis Pharmaceuticals Inc. - Overview
Exhibits130: Ionis Pharmaceuticals Inc. - Business segments
Exhibits131: Ionis Pharmaceuticals Inc. - Key news
Exhibits132: Ionis Pharmaceuticals Inc. - Key offerings
Exhibits133: Ionis Pharmaceuticals Inc. - Segment focus
Exhibits134: Mitsubishi Chemical Corp. - Overview
Exhibits135: Mitsubishi Chemical Corp. - Business segments
Exhibits136: Mitsubishi Chemical Corp. - Key offerings
Exhibits137: Mitsubishi Chemical Corp. - Segment focus
Exhibits138: Nippon Shinyaku Co. Ltd. - Overview
Exhibits139: Nippon Shinyaku Co. Ltd. - Business segments
Exhibits140: Nippon Shinyaku Co. Ltd. - Key offerings
Exhibits141: Nippon Shinyaku Co. Ltd. - Segment focus
Exhibits142: Novartis AG - Overview
Exhibits143: Novartis AG - Business segments
Exhibits144: Novartis AG - Key offerings
Exhibits145: Novartis AG - Segment focus
Exhibits146: Pfizer Inc. - Overview
Exhibits147: Pfizer Inc. - Product / Service
Exhibits148: Pfizer Inc. - Key news
Exhibits149: Pfizer Inc. - Key offerings
Exhibits150: PTC Therapeutics Inc. - Overview
Exhibits151: PTC Therapeutics Inc. - Product / Service
Exhibits152: PTC Therapeutics Inc. - Key offerings
Exhibits153: Sanofi - Overview
Exhibits154: Sanofi - Business segments
Exhibits155: Sanofi - Key news
Exhibits156: Sanofi - Key offerings
Exhibits157: Sanofi - Segment focus
Exhibits158: Sarepta Therapeutics Inc - Overview
Exhibits159: Sarepta Therapeutics Inc - Product / Service
Exhibits160: Sarepta Therapeutics Inc - Key offerings
Exhibits161: SGPharma Pvt. Ltd. - Overview
Exhibits162: SGPharma Pvt. Ltd. - Product / Service
Exhibits163: SGPharma Pvt. Ltd. - Key offerings
Exhibits164: Viatris Inc. - Overview
Exhibits165: Viatris Inc. - Business segments
Exhibits166: Viatris Inc. - Key news
Exhibits167: Viatris Inc. - Key offerings
Exhibits168: Viatris Inc. - Segment focus
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations